The Post Office Put Fentanyl on a Stamp. The Surcharge Goes to Addiction Research.

The federal government's most recognizable public-health campaign surface is not a billboard or a website. It is the corner of an envelope, seen by millions of people who never go looking for it. On October 6, at a ceremony at the National Institutes of Health in Bethesda, the U.S. Postal Service added fentanyl to that surface, issuing a stamp titled Know the Facts About Fentanyl.

It is a semipostal stamp, which is the postal term for a stamp sold above the standard first-class rate so the surcharge can be directed to a cause in the national interest. The current semipostal price is $1. After postage and the Postal Service's costs are covered, the net proceeds go by law to a chosen federal agency: for this stamp, the National Institute on Drug Abuse, the largest public funder of research into substance use, addiction treatment and recovery.

What a semipostal stamp is, and why it is a rare instrument

USPS has issued six semipostal stamps since Congress authorized the program in 1998. Four are still on sale: Breast Cancer Research, Alzheimer's, Healing PTSD and Save Vanishing Species. Fentanyl is the fifth in the current lineup and the first aimed specifically at the overdose crisis, which makes it an unusual piece of drug policy — a funding mechanism that rides on ordinary mail rather than on an appropriation.

At the dedication, Peter Pastre, the Postal Service's vice president for government relations and public policy, put the death toll plainly: fentanyl contributes to some 80,000 overdose deaths each year. NIH director Jay Bhattacharya framed the stamp as an appeal to national resolve, saying the research the stamp funds is what produces new treatments. NIDA director Nora Volkow tied the design to the science of recovery itself, noting that research shows recovery is sustained through meaningful interpersonal connection — family, friends and peers — and that a stamp is a fitting carrier for that message because stamps travel and connect one person to another.

That is essentially the stamp's caption — except the image carries no text at all.

The design deliberately avoids the obvious picture

Drug-awareness artwork reaches quickly for the syringe or the pill, and the Postal Service's art director, Antonio Alcalá, decided not to. He wanted to convey support without imagery that could be triggering to someone in recovery from misuse, so he commissioned illustrator Whitney Sherman, who had drawn the hugely successful Breast Cancer Research semipostal. Sherman's composition places one person at the center, surrounded by a diverse group of supporters who show care through posture and gaze; the central figure receives that support without shame. The word in her head throughout, she said, was hope.

The stamp is available in sheets of 20 at Post Office locations and on the USPS store, and the campaign is circulating under the hashtag #FentanylSemipostalStamp. It arrives during a period when the supply-side picture has at least partly improved: USPS notes that 2024 data showed a historic decline in fentanyl-involved deaths, down more than 30 percent from the previous year.

A stamp will not close a treatment gap or stock a rural clinic with buprenorphine. What it does is put the crisis in front of people who are not reading about it, and turn a routine purchase into a small contribution to the research budget behind opioid addiction treatment. For a country that has spent years arguing about how to talk to the public about fentanyl, a postage stamp is a modest, unusually literal answer: one envelope at a time.